Return of the Great Sage

We have never doubted the abilities of the big brothers.

Does Hengrui have a crisis?

An announcement detonated the medical circle

On July 9th, when the A shares just closed, Hengrui Medicine issued an announcement that Zhou Yunshu, chairman and general manager, resigned from the above position due to physical reasons.

Everyone's speculations are relatively consistent.

However, these operational stumblings obviously cannot make Hengrui, who has always been prudent, a crisis, let alone a young marshal who has worked hard at Hengrui for 17 years as the general manager of Hengrui to leave the field as a matter of course

Sun Piaoyang is most praised in the industry for two characteristics: "Research and development, there are plans.

However, Sun Dasheng came back

Reform is just commonplace for reformers

China’s famous entrepreneurs can be roughly divided into three generations, such as Liu Chuanzhi, Chu Shijian, who are "satisfying fans", Zhang Jindong and Wang Jianlin who are "dinners", Ma Yun, Huang Zheng, and Zhang Yiming who are "drinking tea and eating"

Liu Chuanzhi were generally born before the founding of the People’s Republic of China.

The Mesozoic entrepreneurs have caught up with the best times.

The younger generation of entrepreneurs has taken advantage of technology.

Sun Piaoyang is closer to the Mesozoic in age, but closer to the older generation in >

But Sun Piaoyang is even more a reformer

What's more, Hengrui was approved for 8 drugs in the first half of the year, holding more than 40 pipelines under research, fast follow the rivers and lakes, and the toolbox is full.

Why is Dasheng coming back?

"The King of Medicine" is different from the "Godfather of Zhongguancun"

The godfather of Zhongguancun came out of Qishan three times, and the association was lost.

It is also a comeback to take the banner again, but Sun Piaoyang and Liu Chuanzhi's personalities are different

Hengrui is different.
The 2020 annual report recorded operating income of 27.
735 billion yuan, net profit of 6.
328 billion yuan, and net interest rate of 23%.
This is the characteristic of the high-net-worth pharmaceutical industry
.
What's more, Sun Piaoyang has always insisted on independent research and development, the combination of imitation and innovation, and looked at the boos of generic drugs with cold eyes.
He has not lost the mirage of innovative drugs, and has always maintained a polite distance from capital.
Costs and risks have been stubbornly manipulated
.

There is no reason to come back
.

The Great Sage is here to learn the scripture

A while ago, an article "The Past of China's Innovative Drugs" blasted the circle of medical friends, but the time coordinate was locked in 6 years ago, and it was somewhat disappointing
.

In fact, when talking about the "Chinese pharmaceutical past", it is not much more special than the car past and the refrigerator past.
The beginning of the story is always surprisingly similar-a young man enters a state-owned pharmaceutical factory that is on the verge of bankruptcy.
.
.

In that magnificent age, all the small boats floated in one direction
.

Chinese pharmaceutical people are accustomed to the hardship of "sit on a cold bench", have seen the farce of "how bold people are and how high-yielding drugs are", and have experienced the magic of "90% of the global antibiotics are produced in China".
The policy encourages clinical value.
Such a simple guiding ideology, it is impossible to cause a wave of waves in Sun Dasheng's heart, who is accustomed to seeing the changes
.

Eighty-one could hardly stop Sun Dasheng
.

The difficulty is that without Tang Seng, there would be no direction to learn from the scriptures
.

For the market value of 600 billion, it is not worthy of Sun Piao, but there is a reason for it
.

I believe that for every pharmaceutical person, there is an RNP (Roche, Novartis, Pfizer) dream.
One day, Chinese pharmaceutical companies can become MNCs, and can even compete with these century-old giants
.
Let the pharmaceutical industry, like the developed countries, become a pillar industry of national output and truly benefit all living beings
.

But a hundred years is too long, and the Chinese are used to fighting for the day
.

When approved in two years, three years of listing will become standard; when capital is personally off the market to mass-produce innovative pharmaceutical companies; when sellers are more enthusiastic than gold diggers; when two listings are just admission tickets, three listings have begun to guarantee two (Huanggang, Meiying, and Baekje will soon be listed in China, Hong Kong, and the United States).
When innovation loses its definition and rules are less awe-inspiring, the pharmaceutical industry has changed from a big water and a big fish to a big forest.
It is bizarre and bizarre, and people can’t understand it for a moment.
If you don’t understand, naturally you can’t sit still
.

So when the Great Sage came back this time, the first thing might be to sit in the office next to Huaguo Mountain, take out his mobile phone to turn on the navigation, call up the voice assistant, read the end points circled on the map many years ago, and look carefully at those that have never been.
For the routes that have been used, consider which one is more toll and which one is the longest?

This time there is no Tripitaka, which way would the Great Sacred Society choose?